Equity Overview
Price & Market Data
Price: $5.00
Daily Change: +$0.30 / 6.00%
Daily Range: $4.76 - $5.00
Market Cap: $127,203,616
Daily Volume: 12,163
Performance Metrics
1 Week: -30.68%
1 Month: -25.16%
3 Months: -14.55%
6 Months: -57.47%
1 Year: -54.63%
YTD: -58.11%
Company Details
Employees: 3
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.